Category: Include on Menu

Legend Biotech Corporation (NASDAQ:LEGN) shares gained 5.5% in pre-market trading on Tuesday after the pharmaceutical company delivered better-than-expected second-quarter earnings and revenue, supported by continued growth in CARVYKTI sales. Adjusted earnings came in at $0.16 per share, more than double the analyst consensus of $0.07. Revenue reached $387.5 million, ahead of the $362.81 million estimate…

Autolus Therapeutics plc (NASDAQ:AUTL) shares rose 3.19% in pre-market trading on Tuesday after the biotechnology company delivered better-than-expected second-quarter results and raised its full-year revenue guidance for AUCATZYL. Autolus reported a loss of $0.15 per share, narrower than the consensus forecast for a $0.23 loss. Revenue reached $45.7 million, comfortably exceeding the $30.1 million analyst…

ACV Auctions (NASDAQ:ACVA) shares jumped 12% on Tuesday following a report that the digital automotive marketplace is exploring strategic alternatives, including a potential sale, after attracting takeover interest. Bloomberg reported that the Buffalo, New York-based company is working with financial advisers on the review. ACV is also considering a strategic partnership as another possible option.…

Broadwind Energy Inc. (NASDAQ:BWEN) shares fell 5.83% in pre-market trading on Tuesday after the precision manufacturer reported second-quarter revenue and earnings below analyst expectations, despite substantial year-on-year growth following its exit from wind tower manufacturing. Broadwind reported a loss from continuing operations of $0.03 per share, compared with the consensus estimate for a $0.01 loss.…

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) shares jumped 7.88% in pre-market trading on Tuesday after the specialty pharmaceutical company reported second-quarter earnings and revenue above analyst expectations, supported by continued growth in PEDMARK sales. Adjusted earnings came in at $0.05 per share, exceeding the analyst consensus of $0.02 by $0.03. Revenue reached $17.87 million, ahead of the…

First Advantage (NASDAQ:FA) shares fell 8% on Tuesday morning after investment funds affiliated with Silver Lake Group announced plans to sell 12.5 million shares of the background screening and identity solutions company through a secondary offering. According to Bloomberg, the shares are being marketed at between $22.20 and $23.59 each. First Advantage shares closed Monday…

Bicara Therapeutics Inc. (NASDAQ:BCAX) shares gained 3.32% in pre-market trading on Tuesday after the clinical-stage biopharmaceutical company reported continued enrollment progress in its pivotal FORTIFI-HN01 study and maintained its timeline for an interim analysis in 2027. The company reported a second-quarter loss of $0.82 per share for the period ended June 30, 2026. Net loss…

CalciMedica, Inc. (NASDAQ:CALC) shares rose 6.22% in pre-market trading on Tuesday despite the clinical-stage biopharmaceutical company reporting a wider-than-expected second-quarter loss, as investors focused on progress across its pulmonary hypertension programme and regulatory pipeline. CalciMedica reported a quarterly loss of $0.45 per share, compared with the analyst estimate for a loss of $0.26 per share.…

Harvard Bioscience Inc. (NASDAQ:HBIO) reported better-than-expected second-quarter results on Tuesday and raised its full-year 2026 revenue outlook after stronger demand across its telemetry and cellular and molecular technology businesses. The company posted an adjusted loss of $0.14 per share, considerably narrower than the consensus estimate for a $0.38 loss per share. Revenue increased 11% year…

ECARX Holdings Inc. (NASDAQ:ECX) shares gained 3.62% in pre-market trading on Tuesday after the automotive intelligence technology company reported strong second-quarter revenue growth, improved margins and a substantially narrower net loss. For the quarter ended June 30, ECARX recorded a loss of $0.03 per share, while revenue climbed 45% year on year to $225.2 million…